Patent ID: 8911991

Claim:
A dosage unit comprising at least first and second separate compositions, the first composition containing an ALVAC(2) expression vector encoding CD80 (SEQ ID NO: 14), ICAM-1 (SEQ ID NO: 16), LFA-3 (SEQ ID NO: 15), gp100M (SEQ ID NO: 10), MART-1 (SEQ ID NO: 11), and the MAGE1/3 minigene (nucleotides 8111-8254 of SEQ ID NO.:5), and the second composition comprising an ALVAC(2) expression vector encoding CD80 (SEQ ID NO: 14), ICAM-1 (SEQ ID NO: 16), LFA-3 (SEQ ID NO: 15), TRP-2 (SEQ ID NO: 8, and NY-ESO-1 (SEQ ID NO: 7), wherein administration of the compositions to a host results in an immune response in the host against gp100, MART-1 and NY-ESO-1.